ENTRY       D10752            Mixture   Drug
NAME        Empagliflozin and metformin;
            Synjardy (TN)
PRODUCT     SYNJARDY (Boehringer Ingelheim Pharmaceuticals)
COMPONENT   Empagliflozin [DR:D10459], (Metformin hydrochloride [DR:D00944] | Metformin [DR:D04966])
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG03034  Combination of metformin and SGLT2 inhibitor
REMARK      ATC code: A10BD20
            Product: D10752<US>
EFFICACY    Antidiabetic
  DISEASE   Type 2 diabetes mellitus [DS:H00409]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BD Combinations of oral blood glucose lowering drugs
                 A10BD20 Metformin and empagliflozin
                  D10752  Empagliflozin and metformin &lt;US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Antidiabetic Combinations
               Empagliflozin/ Metformin Hydrochloride
                D10752  Empagliflozin and metformin
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG03034  Combination of metformin and SGLT2 inhibitor
                D10752  Empagliflozin and metformin
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               D10752  Empagliflozin and metformin
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10752
DBLINKS     PubChem: 273220348
            ChEBI: 90875
///
